Objective: To compare the diagnostic accuracy of CSF biomarkers and amyloid PET for diagnosing early-stage Alzheimer disease (AD). Methods: From the prospective, longitudinal BioFINDER study, we included 122 healthy elderly and 34 patients with mild cognitive impairment who developed AD dementia within 3 years (MCI-AD). b-Amyloid (Ab) deposition in 9 brain regions was examined with [18F]-flutemetamol PET. CSF was analyzed with INNOTEST and EUROIMMUN ELISAs. The results were replicated in 146 controls and 64 patients with MCI-AD from the Alzheimer’s Disease Neuroimaging Initiative study. Results: The best CSF measures for identifying MCI-AD were Ab42/total tau (t-tau) and Ab42/ hyperphosphorylated tau (p-tau) (area under the curve [AUC] 0.93...
Background:To enhance the accuracy of clinical diagnosis for Alzheimer’s disease (AD), pre-mortem bi...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...
Objective:To compare the diagnostic accuracy of CSF biomarkers and amyloid PET for diagnosing early-...
Supplemental data at Neurology.org Detailed comparison of amyloid PET and CSF biomarkers for identif...
Purpose: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
Purpose: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
PURPOSE: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
Objective To compare PET imaging of tau pathology with CSF measurements (total tau [t-tau] and phosp...
Introduction: We evaluated for two novel automated biomarker assays how cere-brospinal fluid (CSF) a...
To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in A...
Introduction: We evaluated for two novel automated biomarker assays how cere-brospinal fluid (CSF) a...
Introduction: We studied whether fully automated Elecsys cerebrospinal fluid (CSF) immunoassay resul...
Introduction: We studied whether fully automated Elecsys cerebrospinal fluid (CSF) immunoassay resul...
BACKGROUND: To enhance the accuracy of clinical diagnosis for Alzheimer's disease (AD), pre-mortem b...
Background:To enhance the accuracy of clinical diagnosis for Alzheimer’s disease (AD), pre-mortem bi...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...
Objective:To compare the diagnostic accuracy of CSF biomarkers and amyloid PET for diagnosing early-...
Supplemental data at Neurology.org Detailed comparison of amyloid PET and CSF biomarkers for identif...
Purpose: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
Purpose: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
PURPOSE: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-...
Objective To compare PET imaging of tau pathology with CSF measurements (total tau [t-tau] and phosp...
Introduction: We evaluated for two novel automated biomarker assays how cere-brospinal fluid (CSF) a...
To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in A...
Introduction: We evaluated for two novel automated biomarker assays how cere-brospinal fluid (CSF) a...
Introduction: We studied whether fully automated Elecsys cerebrospinal fluid (CSF) immunoassay resul...
Introduction: We studied whether fully automated Elecsys cerebrospinal fluid (CSF) immunoassay resul...
BACKGROUND: To enhance the accuracy of clinical diagnosis for Alzheimer's disease (AD), pre-mortem b...
Background:To enhance the accuracy of clinical diagnosis for Alzheimer’s disease (AD), pre-mortem bi...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...
Objectives:To define CSF -amyloid 1-42 (A(42)) cutpoints to detect cortical amyloid deposition as as...